AN2 Therapeutics, Inc. (ANTX) Q4 2024 Annual Earnings
ANTX·Reported March 25, 2025·Before market open
Diluted EPS came in at $-0.25.
Diluted EPS
$-0.25met estimate
Consensus: $-0.25
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about AN2 Therapeutics, Inc.'s Q4 2024 earnings report.
AN2 Therapeutics, Inc. (ANTX) reported Q4 2024 earnings on March 25, 2025 before market open.
AN2 Therapeutics, Inc. reported diluted EPS of $-0.25 for Q4 2024.
EPS beat the consensus estimate of $-0.25 by $0.00.
You can read the 10-K periodic report (0000950170-25-044366) directly on SEC EDGAR. The filing index links above go to sec.gov.